Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE American:BTX)

2.54
Delayed Data
As of Nov 22
 -0.03 / -1.17%
Today’s Change
2.19
Today|||52-Week Range
3.97
-29.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues1.1M390.0K381.0K1.7M
 
 
 
 
 
Cost of Goods Sold-20.0K57.0K5.0K52.0K
 
 
 
 
 
Depreciation And Amortization826.0K818.0K787.0K831.0K
 
 
 
 
 
 
Operating ExpensesGross Income277.0K-485.0K-411.0K805.0K
 
 
 
 
 
General Expenses11.5M10.8M9.9M10.3M
 
 
 
 
 
Research And Development6.4M5.9M5.7M6.0M
 
 
 
 
 
Total Operating Expenses12.3M11.7M10.7M11.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.3M-11.3M-10.3M-9.5M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.8M
 
 
Pre-Tax Equity Earnings4.3M-10.0M-7.7M31.2M
 
 
 
 
 
Interest Expense On Debt234.0K306.0K413.0K10.0K
 
 
 
 
 
Other Expenses-601.0K72.4M2.4M-143.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.7M50.9M-16.1M18.8M
 
 
 
 
 
Income Taxes0.00-3.9M-3.9M-4.8M
 
 
 
 
Minority Interest-2.7M-2.3M-576.0K-335.0K
 
 
 
 
 
Net Income-5.1M49.3M-11.7M14.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.8M106.7M110.9M115.3M
 
 
 
 
 
Shares To Calculate EPS Diluted102.8M107.4M110.9M115.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05$0.46-$0.11$0.12
 
 
 
 
 
EPS Diluted-$0.05$0.46-$0.11$0.12